Shenzhen Chipscreen Biosciences Co., Ltd. reported earnings results for the first quarter ended March 31, 2024. For the first quarter, the company reported sales was CNY 130.6 million compared to CNY 106.53 million a year ago. Net loss was CNY 18.3 million compared to CNY 32.48 million a year ago.

Basic loss per share from continuing operations was CNY 0.0448 compared to CNY 0.0798 a year ago. Diluted loss per share from continuing operations was CNY 0.0448 compared to CNY 0.0798 a year ago.